Rep. Jefferson Shreve Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative Jefferson Shreve (R-Indiana) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on March 09th, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on February 24th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of RTX NYSE: RTX on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Royal Gold NASDAQ: RGLD on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of QUALCOMM NASDAQ: QCOM on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 2/24/2025.
• Sold $15,001 - $50,000 in shares of Norfolk Southern NYSE: NSC on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 2/24/2025.
• Purchased $50,001 - $100,000 in shares of AbbVie NYSE: ABBV on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of The Cigna Group NYSE: CI on 2/24/2025.
• Purchased $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 2/24/2025.

UnitedHealth Group Stock Up 1.3 %

UnitedHealth Group stock traded up $6.32 during midday trading on Tuesday, hitting $486.54. 4,100,487 shares of the stock were exchanged, compared to its average volume of 4,993,668. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a 50 day moving average price of $513.21 and a two-hundred day moving average price of $552.69. The firm has a market cap of $445.04 billion, a P/E ratio of 31.39, a P/E/G ratio of 1.37 and a beta of 0.62.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.73%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $341,000. GSG Advisors LLC increased its position in UnitedHealth Group by 14.4% during the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate's stock worth $435,000 after purchasing an additional 94 shares in the last quarter. Principal Financial Group Inc. grew its position in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $91,000. Finally, AEGON ASSET MANAGEMENT UK Plc grew its position in UnitedHealth Group by 0.9% in the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 84,382 shares of the healthcare conglomerate's stock valued at $49,323,000 after acquiring an additional 769 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Buy" and an average price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.33% of the company's stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.